Malaria infection starts when sporozoites are transmitted to the mammalian host during a mosquito bite. Sporozoites enter the blood circulation, reach the liver and infect hepatocytes. The formation of a parasitophorous vacuole (PV), establishes their intracellular niche. Recently, two members of the 6-cys domain protein family, P52 and P36, were shown to each play an important albeit non-essential role in Plasmodium berghei sporozoite infectivity for the rodent host. Here, we generated p52(-)/p36(-) deficient Plasmodium yoelii parasites by simultaneous deletion of both genes using a single genetic manipulation. 
INTRODUCTION
Plasmodium parasites have multiple and distinct stages that constitute their complex life cycle in the mosquito vector and mammalian host. The parasite's invasive stages actively infect cells of the mammalian host wherein replication occurs to produce the next generation of infectious forms. Invasive sporozoites that are transmitted by the bite of a female Anopheles mosquito infect hepatocytes and initiate the liver stage (LS) phase, which grows and leads to development of red blood cell-infectious merozoites (19, 24) . Because malaria pathology is exclusively associated with blood stage infection, a vaccine that efficiently targets the sporozoite and/or LS could completely prevent the onset of disease.
Once deposited into the host skin by mosquito bite, the motile sporozoites actively enter blood vessels and are transported by the blood circulation to the liver (36) . In the liver, they cross the vascular endothelium by passage through resident Kupffer cells in order to reach the space of Disse (1, 6) . This allows them free access to hepatocytes (11) . Sporozoites traverse several hepatocytes (5, 20) before they infect a single hepatocyte by forming a replication-permissive parasitophorous vacuole (PV) compartment. The molecular mechanisms that control the parasites' complex journey and the final establishment of an intrahepatocytic niche are poorly understood but a number of sporozoite proteins on the cell surface or in the secretory organelles have emerged as critical for distinct steps (14) . Best studied are the circumsporozoite protein, CSP and the thrombospondin-related anonymous protein, TRAP. CSP and TRAP are involved in various steps of mammalian host infection such as gliding motility, host cell recognition and host cell invasion. Parasites lacking CSP do not form sporozoites within oocysts (18) and parasites lacking TRAP completely lose the ability to infect the mosquito salivary glands and hepatocytes (29) . More recently sporozoite microneme protein essential for cell traversal 1 (SPECT1) (11) , the Plasmodium perforin-like protein 1 (PPLP1) (9, 12) and the cell traversal protein for ookinete and sporozoite activity (CelTOS) (16) were specifically implicated in cell traversal. However, parasites with a targeted disruption of the genes encoding cell traversal-associated proteins retain
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on August 29, 2017 by guest http://iai.asm.org/ Downloaded from their ability to infect and grow in hepatocytes. Recently two additional proteins, P52 (also termed P36p) (15) and P36 (31) have been implicated in sporozoite infection of hepatocytes by P. berghei but not gliding motility or cell traversal (10, 34) . P52 and P36 are members of the 6-cys protein superfamily characterized by domains with six position-conserved cysteines, a structure unique to Plasmodium species (3). Eight genes from this family are arranged as paralogous gene pairs. P52 and P36 are arranged in tandem in the genome of P. yoelii (contig MALPY00354) and other Plasmodium species. Different members of the 6-cys superfamily are expressed in distinct parasite stages. The gametocyte-expressed members P48/45 are critical for gamete fertilization and P230 is important for the interaction of male gametes with red blood cells (4, 35) . Thus, 6-cys proteins are likely parasite ligands that mediate interaction between gametes or the interaction of parasites and host cells. Interestingly a recent structure prediction analysis showed similarity between 6-cys proteins and Toxoplasma gondii SAG1 (surface antigen 1), a member of the glycosylphosphatidylinositol (GPI)-linked surface proteins, which mediates attachment to host cells (7) . P52 and P36 are uniquely expressed in sporozoites. A lack of P52 which localized to the secretory micronemes shows a significant but not complete reduction of infectivity for the mammalian host (10, 34) . These two studies showed conflicting results concerning the phenotype of p52(-) parasites. Ishino et al. (10) found that p52(-) parasites significantly increased their cell traversal activity and could form a PV upon invasion. In contrast, van Dijk et al. (34) did not observe an increase in cell traversal and did not observe a PV late in infection. We have shown that UIS3 and UIS4 (up-regulated in infective sporozoites genes 3 and 4), small membrane proteins of the sporozoite secretory organelles (13) and the LS PV membrane (PVM) are essential for LS development of P. berghei (21, 22) . P. yoelii uis3(-) and uis4(-) sporozoites successfully invade host cells and form the early LS inside an intact PV but they fail to develop and can in consequence not initiate blood-stage infection (30) . Strikingly, parasites that infect the liver but are unable to undergo growth make powerful vaccines. Immunizations with uis3(-) or uis4 (-) sporozoites completely protected mice against subsequent infectious sporozoite challenge (21, 
on August 29, 2017 by guest http://iai.asm.org/ Downloaded from 22). The use of genetically attenuated parasites (GAPs) as a live attenuated malaria vaccine for humans may thus hold great promise but a critical issue to be addressed is the proper complete attenuation of the vaccine (8, 26) . Single gene deletions may not be sufficient to completely attenuate the parasite and therefore vaccination could lead to breakthrough infections. For example, immunization of mice with p52(-) sporozoites protected against subsequent infectious sporozoite challenge but the immunizations led to sporozoite dose-dependant breakthrough infections in a substantial number of animals (10, 34) .
In this study we asked whether deletion of P52 and P36 in the same parasite would lead to a complete block of infectivity for the mammalian host, thus not causing a breakthrough blood stage infection. The tandem arrangement of the genes allowed deletion of both (double knockout) with a single genetic manipulation. We used P. yoelii because its low ID 50 in BALB/c mice (< 10 sporozoites) provides a more sensitive malaria infectivity model in mice as compared to P. berghei infectivity in mice (2) . Simultaneous deletion of P52 and P36 causes a complete loss of P. yoelii sporozoite infectivity for the rodent host even at high-dose sporozoite inoculum. Double knockout p52(-)/p36(-) sporozoites enter and traverse host cells normally but cannot establish a PV early in hepatocyte infection. Using this double knockout as a vaccine in mouse immunizations, we show its efficacy to induce sterile protection against infectious sporozoite challenge by intravenous injection or by mosquito bite.
MATERIAL AND METHODS

Experimental animals
Female Swiss Webster (SW) mice (6-8 weeks) and female Wistar rats (5 weeks) were purchased from HARLAN Company (Indianapolis, USA). Female (6-8 weeks) BALB/c mice were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA). Animal handling was conducted according to the Institutional Animal Care and Use Committee (IACUC) approved protocols. at days 10 and 14 (after the first infectious blood meal) to determine the mean number of midgut oocyst sporozoites and salivary gland sporozoites respectively per mosquito using a hemocytometer.
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In vitro analysis of infection
All the in vitro assays were conducted using the human hepatoma cell line HepG2 expressing the tetraspanin CD81 (HepG2-CD81) (28) The double staining test to differentiate sporozoites outside a host cell versus sporozoites inside a host cell (hepatocyte entry) was performed as published (27) For the infection assay, sporozoites were incubated for 2 hours with HepG2-CD81 cells. The cultures were fixed with 4% paraformaldehyde followed by a permeabilization with 100% methanol for 10 minutes at room temperature. Double staining was performed using anti-PyCSP 9D3 primary Ab followed by Alexa Fluor 488 and anti-PyUIS4 primary Ab followed by Alexa
Fluor 594 goat anti-rabbit IgG (Molecular Probes, Eugene, OR). (FluoroGuard ™ -BIO-RAD -Hercules, CA). Preparations were analyzed using a fluorescenceinverted microscope (Nikon -Eclipse TE2000-E) and images were aquired using Olympus 1X70
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Delta Vision deconvolution microscopy.
For thin-section transmission electron microscopy, 10 6 wt and p52(-)/p36(-) sporozoites were used to infect 10 6 subconfluent HepG2-CD81. One hour post infection, cells were fixed with 2.5% glutaraldehyde (Electron Microscopy Sciences; EMS, Hatfield, PA) in 0.1 M sodium cacodylate buffer (pH 7.4) for 1 hour at room temperature, and processed as described (25) before examination with a Philips 410 Electron Microscope (Eindhoven, the Netherlands) under 80 kV.
In vivo analysis of infection
To analyze in vivo sporozoite infection and LS development, mice were injected by i.v. injection with 2.0×10 6 wt or p52(-)/p36(-) sporozoites. For each parasite population, livers were harvested at time points 2 and 6 hours post injection. Livers were washed extensively with PBS and fixed in 4% PFA. Several 50µm sections were made from each liver using a vibratome (Ted Pella Inc., Reding, CA). Preparations were stained with anti-PyUIS4 primary Ab followed by Alexa Fluor 594 and with anti-PyCSP 9D3 primary Ab followed by Alexa Fluor 488. Preparations were analyzed using a fluorescence-inverted microscope (Nikon -Eclipse TE2000-E) and images were aquired using Olympus 1X70 Delta Vision deconvolution microscopy. 
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RESULTS
Genomic organization and gene targeting strategy
Py52 (GenBank: AF390552 -PlasmoDB: PY01340) and Py36 (GenBank: AABL01000353 -PlasmoDB: PY01341) are paralogous tandem-arranged genes on contig MALPY00354 (Fig. 1A ). followed by two 6-cys domains, but unlike P36, P52 exhibits a C-terminal hydrophobic sequence predicted to be a putative GPI anchor attachment signal (Fig. 1B) .
A replacement targeting plasmid (Fig. 1C ) was made to simultaneously delete the endogenous P52 and P36 genes by double crossover homologuous recombination (17). Two independent transfection experiments were performed using the Nucleofector® device. Transfected parasites (Fig. 1D) . Two independent p52/p36-disrupted clones, p52(-)/p36(-) Cl1 and Cl2 were generated and used for phenotypic analysis. sporozoites in midguts (data not shown) and in salivary glands (Table 1) . RT-PCR confirmed the lack of P52 and P36 transcripts in p52(-)/p36(-) salivary gland sporozoites (Fig. 1E) . RT-PCR using CSP oligonucleotide primers was used as a positive transcript control and CSP expression appeared unchanged in p52(-)/p36(-) salivary gland sporozoites (Fig. 1E ).
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p52(-)/p36(-) sporozoites traverse cells normally but fail to establish an infection in vitro
We investigated the ability of Py52(-)/36(-) sporozoites to enter host cells in vitro using HepG2-CD81 cells. Our choice to use the HepG2 hepatoma cells expressing a human CD81 is based on their high susceptibility to P. yoelii sporozoite infection and efficient LS development (28) . The level of hepatocyte entry was determined by counting the number of sporozoites inside host cells relative to those outside host cells (Table 1) . On average, 1000 sporozoites were counted within a well an hour after infection. The number of intracellular p52(-)/p36(-) parasites showed a ~50% reduction when compared to wt sporozoites (Table 1) . We next examined the cell-traversal ability (Fig. 2A ) using flow cytometry.
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Several independent experiments with wt and p52(-)/p36(-) sporozoites consistently showed that ~20% of the total number of cells per culture were fluorescent, i. e. had been wounded (Fig. 2B ).
These data demonstrate the ability of p52(-)/p36(-) sporozoites to traverse cells normally. The successful infection of hepatocytes that leads to productive LS development requires formation of a PV compartment during invasion by sporozoites. To assess this activity, we performed immunoflourescence analysis to localize UIS4, a resident protein of the PV membrane (PVM) and in its associated tubovesicular network (21) . Two hours after infection of HepG2-CD81 cells with wt sporozoites, early LS exhibiting a circumferential UIS4 staining were easily detectable (Fig. 3A) . Strikingly, p52(-)/p36(-) parasites did not show this UIS4 staining pattern (Fig. 3A) .
Quantitative analysis showed complete absence of circumferential UIS4 staining in p52(-)/p36(-)
parasites (Fig. 3B) . In wt parasites, we found that ~ 40% of parasites had infected host cells and exhibited circumferential UIS4 staining. Further analysis using de-convolution microscopic observations at higher magnification showed a strong UIS4 staining pattern entirely surrounding the invaded wt sporozoites (Fig. 3C) . However, intracellular p52(-)/p36(-) sporozoites exhibited a weak internal staining for UIS4 (Fig. 3C) . Next, we investigated whether p52(-)/p36(-) parasites were able to develop as LS inside host cells by incubation of infected HepG2-CD81 cells for 43
hours. As expected the wt parasite-infected cells showed a high number of late LS schizonts (Fig.   4A ) fully surrounded by UIS4 (Fig. 4B) . However, no p52(-)/p36(-) late LS schizonts were detected after 43 hours. We sporadically observed small-growth arrested parasites that did not show typical UIS4 staining (Fig. 4D ). 5A ). We could also detect p52(-)/p36(-) parasites in the liver sections by CSP staining but they did not show UIS4 staining. ∼75% of the total wt parasites but no p52(-)/p36(-) parasites detected at two hours pi showed UIS4-postive circumferential staining, (Fig. 5A, B) . Furthermore, at two
p52(-)/p36(-) sporozoites fail to infect the mammalian host
In order to analyze the relevance of the observed defect in p52(-)/p36(-) sporozoite host cell infection in vivo, we investigated the ability of the p52(-)/p36(-) sporozoites to infect the
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hours pi, we detected less p52(-)/p36(-) parasites (Fig. 5B). We did not detect any p52(-)/p36(-)
parasites in the host liver at six hours pi (data not shown).
p52(-)/p36(-) parasites cannot establish a parasitophorous vacuole
The absence or abnormal localization of the PVM protein UIS4 in intracellular p52(-)/p36 (-) parasites indicated a possible lack of the PVM. To further address this issue we performed an electron microscopic (EM) analysis of intracellular wt and p52(-)/p36(-) parasites one hour after infection of HepG2-CD81 cells. Intracellular wt parasites were clearly surrounded by a PVM (Fig. 6A) . Out of 22 parasites evaluated by EM, 20 exhibited a PVM and 2 appeared free in the cytoplasm. The latter may represent sporozoites in the process of cell traversal. However, all of 14 intracellular p52(-)/p36(-) parasites observed lacked a PVM and were in direct contact with the host cell cytoplasm or freely exposed to the nucleoplasm (Fig. 6B, C) . Together the data demonstrate that p52(-)/p36(-) parasites do not possess a PVM early in infection. 
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DISCUSSION
Only a small number of human malaria parasite salivary gland sporozoites (23, 33) are needed to infect the host. Therefore, sporozoite infection is highly efficient despite the complexity of its journey to the liver. The P. yoelii/BALB/c mouse malaria model is a good infectivity model because of its low ID 50 of less than 10 sporozoites (2). By simultaneous deletion of two putative sporozoite 6-cys superfamily ligands, P52 and P36, we created mutant parasites that cannot successfully infect the mammalian host. We showed that the p52(-)/p36(-) sporozoites are unable to cause a blood stage infection even when inoculated at high doses. Previous studies using P. berghei showed that single knock-out p52(-) or p36(-) sporozoites remained partially infective and caused blood stage infection (10) . ~5% of rats inoculated with 3.0×10 3 p52(-) sporozoites and ~40% of rats inoculated with 3.0×10 3 p36(-) sporozoite became blood stage parasitaemic . The rate of blood stage infection increased with inoculation of higher sporozoite p36(-) sporozoites (10) . The partial infectivity of Pb52(-) sporozoites was also shown using C57BL/6 mice with 10% of mice becoming parasitaemic (34) . Although the Pb52(-) sporozoites conferred protection against infectious sporozoite challenge (34) they were not sufficiently attenuated to consider them as a candidate GAP vaccine because of the relatively high incidence of breakthrough infections. We have shown herein that simultaneous deletion of P52 and P36
A C C E P T E D
creates a completely attenuated parasites. Despite the fact that previous studies and our study used distinct Plasmodium/rodent models, the significant differences between the single and double knockout sporozoite infectivity profiles may allow us to think that P52 and P36 have partially redundant functions. However, P36 is a predicted secreted protein whilst P52 is a predicted GPI anchored protein, thus making it difficult to envision how each protein could partially compensate the loss of the other. A similar case where individual disruptions of paraloguous genes showed a comparable but not complete phenotypic defect was described for P.
berghei ookinete surface proteins P25 and P28 (32) . These proteins are partially redundant with similar functions during the ookinete/oocyst transition. Simultaneous disruption of these genes showed an almost complete loss (>99%) of oocysts.
Phenotypic analysis of p52(-) and p36(-) sporozoites by Ishino et al. (10) showed that the single knockout P. berghei parasites could infect HepG2 cells with the formation of a PVM albeit with reduced efficiency. This group also observed a significant increase in cell traversal activity of single knockout parasites. The authors speculated that disrupted parasites fail to switch to "infection mode" and keep traversing host cells.
Our observations with P. yoelii p52(-)/p36(-)
sporozoites did not show an increase in traversal activity upon rigorous quantification by flow cytometry. Importantly, by studying the PVM early in infection we demonstrate that p52(-)/p36(-) parasites fail to form a PVM. Thus, it is likely that P52 and P36 are critical in a pathway that leads to the formation of the PVM. We have used HepG2 cells expressing human CD81, which support efficient infection and complete development by P. yoelii. This is not the case for HepG2 interactions between P52/P36 proteins and CD81, which may be needed for PV induction.
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However, this needs to be addressed experimentally. p52(-)/p36(-) parasites remain free in the host cell cytoplasm or move on to penetrate the host cell nucleus. It is possible that the absence of the PVM as a controlled and highly organized LS-hepatocyte interface prevents the parasites' ability to establish an efficient system of nutrient uptake and this leads to growth arrest. In addition, PVM-free LS could be prone to attack by the host cell and may therefore quickly be eliminated. In agreement with this scenario, we did not observe any growth-arrested parasites in 
Py52(-)/36(-) Cl1
Py52(-)/36(-) Cl2
Pywt clone + CytD b For this specific test hepatocyte entry is defined as the sporozoite's ability to cross a host cell membrane and to enter the cell . Sporozoites were counted in at least three different wells. Eight fields per well were examined.
c Experiments were done in duplicate. 
